Total Payments
$755.01
2023 Payments
$53.72
Companies
12
Transactions
43
Medicare Patients
2,868
Medicare Billing
$324,661
Payment Breakdown by Category
Food & Beverage$755.01 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $755.01 | 43 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Nestle HealthCare Nutrition Inc. | $158.48 | 9 | $0 (2022) |
| ABBVIE INC. | $138.84 | 6 | $0 (2022) |
| Teva Pharmaceuticals USA, Inc. | $104.10 | 6 | $0 (2021) |
| AstraZeneca Pharmaceuticals LP | $92.60 | 5 | $0 (2021) |
| PFIZER INC. | $67.79 | 4 | $0 (2023) |
| Lilly USA, LLC | $56.70 | 3 | $0 (2021) |
| Mylan Specialty L.P. | $34.81 | 3 | $0 (2021) |
| Amgen Inc. | $25.08 | 2 | $0 (2021) |
| GlaxoSmithKline, LLC. | $20.33 | 1 | $0 (2021) |
| Biohaven Pharmaceutical Holding Company Ltd. | $19.80 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $53.72 | 3 | PFIZER INC. ($53.72) |
| 2022 | $63.85 | 3 | ABBVIE INC. ($27.46) |
| 2021 | $637.44 | 37 | Nestle HealthCare Nutrition Inc. ($141.89) |
All Payment Transactions
43 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/01/2023 | PFIZER INC. | PAXLOVID (Drug) | Food and Beverage | In-kind items and services | $15.21 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 05/09/2023 | PFIZER INC. | PAXLOVID (Drug) | Food and Beverage | In-kind items and services | $16.79 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 01/31/2023 | PFIZER INC. | PAXLOVID (Drug) | Food and Beverage | In-kind items and services | $21.72 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 03/16/2022 | Biohaven Pharmaceutical Holding Company Ltd. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $19.80 | General |
| Category: PRIMARY CARE | ||||||
| 03/09/2022 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $27.46 | General |
| Category: NEUROSCIENCE | ||||||
| 01/05/2022 | Nestle HealthCare Nutrition Inc. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $16.59 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 12/03/2021 | Genentech USA, Inc. | Xofluza (Drug) | Food and Beverage | In-kind items and services | $4.24 | General |
| Category: Virology & Specialty Care | ||||||
| 10/05/2021 | AbbVie Inc. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $24.58 | General |
| Category: NEUROSCIENCE | ||||||
| 09/30/2021 | Nestle HealthCare Nutrition Inc. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $21.18 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 09/29/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $27.63 | General |
| Category: NEUROSCIENCE | ||||||
| 08/26/2021 | Nestle HealthCare Nutrition Inc. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $21.02 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 07/21/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $18.48 | General |
| Category: NEUROSCIENCE | ||||||
| 07/21/2021 | PFIZER INC. | PREMARIN (Drug), COLOGUARD DNA CAPTURE REAGENTS | Food and Beverage | In-kind items and services | $14.07 | General |
| Category: WOMENS HEALTH | ||||||
| 06/23/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $22.19 | General |
| Category: NEUROSCIENCE | ||||||
| 06/22/2021 | Nestle HealthCare Nutrition Inc. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $19.89 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 06/15/2021 | GlaxoSmithKline, LLC. | SHINGRIX (Biological) | Food and Beverage | In-kind items and services | $20.33 | General |
| Category: VACCINES | ||||||
| 06/04/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $18.50 | General |
| Category: NEUROSCIENCE | ||||||
| 05/26/2021 | Teva Pharmaceuticals USA, Inc. | AirDuo Digihaler (Drug) | Food and Beverage | In-kind items and services | $12.07 | General |
| Category: Respiratory | ||||||
| 05/20/2021 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $13.68 | General |
| 05/13/2021 | Nestle HealthCare Nutrition Inc. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $20.09 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 04/29/2021 | Mylan Specialty L.P. | Yupelri (Drug), Perforomist | Food and Beverage | In-kind items and services | $11.22 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 04/27/2021 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $22.30 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 04/23/2021 | Teva Pharmaceuticals USA, Inc. | AirDuo Digihaler (Drug) | Food and Beverage | In-kind items and services | $13.55 | General |
| Category: Respiratory | ||||||
| 04/14/2021 | Amgen Inc. | Aimovig (Biological), Otezla | Food and Beverage | In-kind items and services | $13.63 | General |
| Category: Neuroscience | ||||||
| 04/07/2021 | Teva Pharmaceuticals USA, Inc. | AJOVY (Biological) | Food and Beverage | In-kind items and services | $19.40 | General |
| Category: Central Nervous System | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 509 | 593 | $63,560 | $33,064 |
| 2022 | 17 | 924 | 1,005 | $209,453 | $154,876 |
| 2021 | 17 | 885 | 925 | $150,053 | $108,960 |
| 2020 | 13 | 550 | 634 | $66,301 | $27,761 |
Total Patients
2,868
Total Services
3,157
Medicare Billing
$324,661
Procedure Codes
54
All Medicare Procedures & Services
54 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 203 | 242 | $38,910 | $19,000 | 48.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 84 | 84 | $14,700 | $8,660 | 58.9% |
| 87426 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | Office | 2023 | 79 | 81 | $4,050 | $2,770 | 68.4% |
| 87804 | Detection test by immunoassay with direct visual observation for influenza virus | Office | 2023 | 35 | 72 | $1,800 | $1,168 | 64.9% |
| 87880 | Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) | Office | 2023 | 42 | 44 | $880.00 | $712.80 | 81.0% |
| 71046 | X-ray of chest, 2 views | Office | 2023 | 27 | 28 | $2,380 | $614.04 | 25.8% |
| 81002 | Urinalysis, manual test | Office | 2023 | 39 | 42 | $840.00 | $139.81 | 16.6% |
| Q0222 | Injection, bebtelovimab, 175 mg | Office | 2022 | 102 | 102 | $52,672 | $51,616 | 98.0% |
| M0222 | Intravenous injection, bebtelovimab, includes injection and post administration monitoring | Office | 2022 | 102 | 102 | $51,000 | $36,792 | 72.1% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 109 | 109 | $29,975 | $19,808 | 66.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 147 | 166 | $24,900 | $13,021 | 52.3% |
| M0247 | Intravenous infusion, sotrovimab, includes infusion and post administration monitoring | Office | 2022 | 24 | 24 | $12,000 | $11,288 | 94.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 97 | 97 | $16,950 | $10,490 | 61.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 19 | 19 | $3,875 | $2,819 | 72.7% |
| 87426 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | Office | 2022 | 73 | 81 | $4,050 | $2,779 | 68.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 35 | 40 | $4,600 | $2,308 | 50.2% |
| 87804 | Detection test by immunoassay with direct visual observation for influenza virus | Office | 2022 | 39 | 80 | $2,000 | $1,306 | 65.3% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 13 | 13 | $1,950 | $868.06 | 44.5% |
| 71046 | X-ray of chest, 2 views | Office | 2022 | 33 | 36 | $3,060 | $744.20 | 24.3% |
| 87880 | Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) | Office | 2022 | 31 | 34 | $680.00 | $555.04 | 81.6% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2022 | 18 | 18 | $540.00 | $188.05 | 34.8% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2022 | 21 | 21 | $420.00 | $161.33 | 38.4% |
| 81002 | Urinalysis, manual test | Office | 2022 | 37 | 39 | $780.00 | $130.50 | 16.7% |
| Q0247 | Injection, sotrovimab, 500 mg | Office | 2022 | 24 | 24 | $1.20 | $1.20 | 100.0% |
| M0243 | Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring | Office | 2021 | 107 | 107 | $49,300 | $47,766 | 96.9% |
About Ellen Brady, NP
Ellen Brady, NP is a Family healthcare provider based in Smithfield, Rhode Island. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/25/2017. The National Provider Identifier (NPI) number assigned to this provider is 1578080909.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Ellen Brady, NP has received a total of $755.01 in payments from pharmaceutical and medical device companies, with $53.72 received in 2023. These payments were reported across 43 transactions from 12 companies. The most common payment nature is "Food and Beverage" ($755.01).
As a Medicare-enrolled provider, Brady has provided services to 2,868 Medicare beneficiaries, totaling 3,157 services with total Medicare billing of $324,661. Data is available for 4 years (2020–2023), covering 54 distinct procedure/service records.
Ad
Practice Information
- Specialty Family
- Location Smithfield, RI
- Active Since 08/25/2017
- Last Updated 08/08/2018
- Taxonomy Code 363LF0000X
- Entity Type Individual
- NPI Number 1578080909
Products in Payments
- ZENPEP (Drug) $158.48
- UBRELVY (Drug) $86.80
- FARXIGA (Drug) $63.07
- PAXLOVID (Drug) $53.72
- QULIPTA (Drug) $52.04
- AUSTEDO (Drug) $44.16
- AirDuo Digihaler (Drug) $40.54
- Yupelri (Drug) $34.81
- EMGALITY (Drug) $29.50
- TRULICITY (Drug) $27.20
- Aimovig (Biological) $25.08
- SHINGRIX (Biological) $20.33
- NURTEC ODT (Drug) $19.80
- AJOVY (Biological) $19.40
- Xofluza (Drug) $19.21
- Carnation Ambulatory Monitor (Device) $17.27
- PREMARIN (Drug) $14.07
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Smithfield
Mr. Mark Clarke, Npp32626, NPP32626
Family — Payments: $29,684
Family $29,684
Nichole Wilson, Msn, Fnp-C, MSN, FNP-C
Family — Payments: $9,329
Family $9,329
Ms. Ashley Liese, Np-C, NP-C
Family — Payments: $8,480
Family $8,480
Abbey Barkley Davis, Np, NP
Family — Payments: $7,026
Family $7,026
Leslie Ann Dupree, Fnp, FNP
Family — Payments: $3,979
Family $3,979
Ms. Christina Peacock, Fnp, FNP
Family — Payments: $3,578
Family $3,578